Welcome to our dedicated page for Metropolitan Bank SEC filings (Ticker: MCB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Metropolitan Bank Holding Corp. (NYSE: MCB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Metropolitan Bank Holding Corp. is the parent company of Metropolitan Commercial Bank, a New York City based full-service commercial bank that is a New York State chartered commercial bank, a member of the Federal Reserve System and the FDIC, and an equal housing lender.
Through this page, users can review current reports on Form 8-K, which Metropolitan Bank Holding Corp. uses to announce material events. Recent examples include 8-K filings reporting the release of quarterly financial results and the declaration of quarterly cash dividends on the company’s common stock. These filings often reference accompanying press releases and presentation materials that discuss net interest income, net interest margin, loan and deposit trends, provisions for credit losses, capital ratios and liquidity measures.
In addition to 8-Ks, investors typically consult the company’s annual reports on Form 10-K and quarterly reports on Form 10-Q for more comprehensive information. In its public communications, the company points to these filings for detailed discussions of risk factors, including interest rate risk, credit risk, liquidity and funding considerations, regulatory and compliance matters, technology and cybersecurity risks, and macroeconomic and market-related uncertainties.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key points from long-form filings, helping users quickly identify sections on earnings, capital and liquidity, credit quality, and risk disclosures. Real-time updates from the SEC’s EDGAR system ensure that new filings, such as additional 8-Ks or periodic reports, appear promptly. Users can also monitor filings related to dividends and other board actions that affect Metropolitan Bank Holding Corp. shareholders.
For anyone analyzing MCB as a commercial banking stock, these filings provide the official record of the company’s financial condition, regulatory capital status, and forward-looking statements, as described by management in its SEC reports.
Metropolitan Bank Holding Corp. (MCB) insider sale by Executive Vice President Nick Rosenberg on 09/17/2025. Mr. Rosenberg sold a total of 1,250 shares in three blocks—161 at a weighted average of $78.1163, 339 at $78.8821, and 750 at $80.0242—under a Rule 10b5-1 trading arrangement adopted June 6, 2025. After these transactions his reported direct beneficial ownership decreased from prior levels to 28,339 shares. The filing also notes indirect holdings of 250 shares each for three children and the inclusion of restricted stock units that vest on scheduled anniversaries beginning March 1, 2024 through 2026. The Form 4 was signed by an attorney-in-fact on 09/18/2025.
Metropolitan Bank Holding Corp. (MCB) insider sale by Executive Vice President Nick Rosenberg on 09/17/2025. Mr. Rosenberg sold a total of 1,250 shares in three blocks—161 at a weighted average of $78.1163, 339 at $78.8821, and 750 at $80.0242—under a Rule 10b5-1 trading arrangement adopted June 6, 2025. After these transactions his reported direct beneficial ownership decreased from prior levels to 28,339 shares. The filing also notes indirect holdings of 250 shares each for three children and the inclusion of restricted stock units that vest on scheduled anniversaries beginning March 1, 2024 through 2026. The Form 4 was signed by an attorney-in-fact on 09/18/2025.
Form 144 filed for Metropolitan Bank Holding Corp. (MCB) shows an insider sale program notice and a recent insider sale. The notice lists a proposed sale of 3,750 shares of common stock to be executed through J.P. Morgan Securities on September 17, 2025, with an aggregate market value of $290,475. The company has 10,421,384 shares outstanding, so the proposed sale represents approximately 0.036% of outstanding shares. The filer previously sold 1,250 shares on July 3, 2025 for gross proceeds of $93,815. Acquisition details show the shares to be sold were granted as executive compensation in multiple awards between 2018 and 2021 totaling the amounts listed in the filing. The filer certifies no undisclosed material adverse information.
Form 144 filed for Metropolitan Bank Holding Corp. (MCB) shows an insider sale program notice and a recent insider sale. The notice lists a proposed sale of 3,750 shares of common stock to be executed through J.P. Morgan Securities on September 17, 2025, with an aggregate market value of $290,475. The company has 10,421,384 shares outstanding, so the proposed sale represents approximately 0.036% of outstanding shares. The filer previously sold 1,250 shares on July 3, 2025 for gross proceeds of $93,815. Acquisition details show the shares to be sold were granted as executive compensation in multiple awards between 2018 and 2021 totaling the amounts listed in the filing. The filer certifies no undisclosed material adverse information.
Metropolitan Bank Holding Corp. insider report: Director Dale C. Fredston sold a total of 3,000 shares of the issuer on 09/03/2025 in two sets of transactions. The larger block of 2,841 shares was sold at a weighted-average price of $78.6167 (individual prices ranged $78.05–$79.042). A second block of 159 shares was sold at a weighted-average price of $79.2727 (prices ranged $79.107–$79.36). After these sales the reported beneficial ownership is shown as 14,168 shares (with a prior line showing 14,327 that includes restricted stock units). The filing discloses that restricted stock units vesting 100% on January 27, 2026 are included in the beneficial ownership figure.
Form 144 notice from an insider of Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $235,530 and an approximate sale date of 09/02/2025. The filer acquired 2,500 of the shares as a stock award on 01/24/2025 (compensation) and 500 shares by purchase in the market on 03/19/2020 for cash. There were no securities sold in the past three months by the reporting person, and the filer represents no undisclosed material adverse information. The filing is a routine insider sale notice required under Rule 144.
Robert C. Patent, a director of Metropolitan Bank Holding Corp. (MCB), reported the sale of 5,000 shares of the issuer's common stock on 08/27/2025 at a weighted average price of $79.0194. After the sale, the filing shows 98,685 shares beneficially owned directly (which includes restricted stock units that vest 100% on January 27, 2026), plus 32,882 shares held indirectly via a sibling and 14,445 indirectly via a profit sharing plan. The report includes a power of attorney disclosure regarding the sibling-held shares and notes the sale prices ranged from $78.74 to $79.2237.
Form 144 notice for Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 5,000 shares of common stock through J.P. Morgan Securities with an approximate sale date of 08/27/2025 and an aggregate market value of $395,550. The filing shows total shares outstanding of 10,421,384, and states the 5,000 shares were originally received as board compensation (4,100 shares on 12/08/2016 and 900 shares on 08/11/2018). The notice also lists recent sales by the same holder in the past three months: 5,000 shares on 07/11/2025 (gross proceeds $391,845) and two sales on 08/20/2025 totaling 5,000 shares (gross proceeds $152,891 and $210,840).
Terence J. Mitchell, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of common stock on 08/19/2025. The Form 4 shows 4,796 shares sold at a weighted average price of $72.4401, with prices in the transactions ranging from $72.1801 to $72.5800. After the sale, the reporting person beneficially owns 13,230 shares, which includes restricted stock units that vest 100% on January 27, 2026. The filing indicates the report was signed by an attorney-in-fact on 08/21/2025. All information is limited to the transactions and holdings disclosed on the Form 4.
Robert C. Patent, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of 5,000 shares of the issuer's common stock on 08/19/2025 at a weighted-average price of $72.7460 per share. After the reported transaction, the reporting person directly beneficially owns 103,685 shares.
The filing also shows indirect holdings of 32,882 shares via a sibling (over which the reporting person holds a power of attorney but disclaims beneficial ownership) and 14,445 shares held indirectly through a profit sharing plan. The report notes restricted stock units that vest 100% on January 27, 2026. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/21/2025.
The filing is a Form 144 notification for the proposed sale of 4,796 shares of common stock to be executed on or about 08/19/2025 on the NYSE. The filing lists an aggregate market value of $347,228.36 and reports 10,421,384 shares outstanding. The 4,796 shares were acquired through restricted stock vesting on three dates—12/31/2021 (1,296 shares), 02/01/2023 (1,000 shares) and 01/24/2025 (2,500 shares)—and were issued as fees for service as director. The broker listed for the sale is Osaic Wealth, Inc., with an address in Red Bank, NJ. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Form 144 notice from Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 5,000 common shares through J.P. Morgan Securities LLC with an aggregate market value of $363,700, scheduled approximately for 08/19/2025 on the NYSE. The filing shows those 5,000 shares equal the cumulative shares received as board compensation across multiple grant dates between 2017 and 2023. The issuer has 10,421,384 shares outstanding, and the filer reports no securities sold in the past three months. The signer also certifies they are not aware of any undisclosed material adverse information about the issuer.